[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
March 5, 2003

Pharmacist Care for Reactive Airway DiseasePharmacist Care for Reactive Airway Disease

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;289(9):1103-1106. doi:10.1001/jama.289.9.1103-a

To the Editor: Dr Weinberger and colleagues1 found that patients with asthma who received pharmaceutical care experienced more breathing-related ED visits. It is possible that patients' interactions with the pharmacists resulted in constant reminder of the morbidity of uncontrolled asthma and resulted in a need to seek definitive treatment and further reassurance. The nature of the conversation with the pharmacist could have provided the patients with reinforcement of disease-related symptoms and increased reassurance of their own understanding of the disease. In any event, results suggest that patient-physician interaction may not be adequate to educate patients about chronic disease. Similar trends of improved care of heart failure management with the involvement of pharmacists have been previously reported.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×